Neuroendocrine effects of diazepam in panic and generalized anxiety disorders (Q51158585)

31 March 2018

title

Neuroendocrine effects of diazepam in panic and generalized anxiety disorders (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

22 October 2022

0 references

5

Greenblatt D

1 reference

31 March 2018

Charles Nemeroff

6

object named as

C. Nemeroff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654136

22 October 2022

author name string

Roy-Byrne PP

1

1 reference

31 March 2018

P. P. Roy-Byrne

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654136

22 October 2022

D. S. Cowley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654136

22 October 2022

D. Hommer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654136

22 October 2022

J. Ritchie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654136

22 October 2022

D. Greenblatt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654136

22 October 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

31 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:000632239190072T?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

https://api.elsevier.com/content/article/PII:000632239190072T?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

22 October 2022

published in

Biological Psychiatry

1 reference

31 March 2018

volume

30

1 reference

31 March 2018

issue

1

1 reference

31 March 2018

page(s)

73-80

1 reference

31 March 2018

Blunted growth hormone response to clonidine in patients with generalized anxiety disorder

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.

22 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Intravenous diazepam fails to change growth hormone and cortisol secretion in humans.

22 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Suppression of plasma cortisol after oral administration of oxazepam in man.

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Entry of diazepam and its major matabolite into cerebrospinal fluid.

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Benzodiazepine sensitivity in normal human subjects

22 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Nocturnal and early morning secretion of ACTH and cortisol in humans

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Comparison of growth hormone stimulation induced by desimipramine, diazepam and metaclazepam in man.

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Growth hormone response to intravenous diazepam and placebo in 82 healthy men.

22 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.

22 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.

22 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

22 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Preliminary evidence of benzodiazepine subsensitivity in panic disorder

22 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Reduced benzodiazepine sensitivity in panic disorder

22 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

The dexamethasone suppression test in generalised anxiety disorder

22 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls.

22 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man

22 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

Blunted growth hormone response to clonidine in panic disorder patients

22 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90072-T

22 October 2022

Identifiers

1 reference

31 March 2018

1 reference

31 March 2018